Research Article| Volume 36, SUPPLEMENT 1, S108-S114, September 2010

Download started.


Patterns of care in surgery for ovarian cancer in Europe


      Quality of surgery is one of the most important determinants of the outcome in ovarian cancer patients. Surgery by a gynaecological oncologist in a specialised, high-volume environment and removal of all visible tumours are associated with a higher likelihood of favourable outcome for patients with advanced-stage ovarian cancer. Population-based studies in Europe however show that a substantial number of patients do not receive optimal surgical care. Less than half of the patients suffering from advanced-stage ovarian cancer are operated by a gynaecological oncologists. Also the proportion of patients operated in a high-volume or specialised hospital is lower than 50%. In a substantial number of patients, minimum standard procedures are not performed and optimal tumor debulking is not achieved. To improve the quality of care, efforts are needed to develop and implement robust evidence-based European guidelines, provide surgical training for gynaecological oncologists and establish comprehensive cancer networks with sufficient resources.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bray F.
        • Loos A.H.
        • Tognazzo S.
        • La V.C.
        Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries, 1953–2000.
        Int J Cancer. 2005; 113: 977-990
        • Ferlay J.
        • Parkin D.M.
        • Steliarova-Foucher E.
        Estimates of cancer incidence and mortality in Europe in 2008.
        Eur J Cancer. 2010; 46: 765-781
        • du Bois A.
        • Quinn M.
        • Thigpen T.
        • et al.
        2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).
        Ann Oncol. 2005; 16: viii7-viii12
        • Meigs J.V.
        Tumors of the female pelvic organs.
        MacMillan, New York1934
        • Hoskins W.J.
        • McGuire W.P.
        • Brady M.F.
        • et al.
        The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.
        Am J Obstet Gynecol. 1994; 170: 974-979
        • Chi D.S.
        • Eisenhauer E.L.
        • Lang J.
        • et al.
        What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?.
        Gynecol Oncol. 2006; 103: 559-564
        • Harter P.
        • Hilpert F.
        • Mahner S.
        • et al.
        Prognostic factors for complete debulking in first- and second-line ovarian cancer.
        Int J Gynecol Cancer. 2009 Dec; 19: S14-S17
        • du Bois A.
        • Reuss A.
        • Pujade-Lauraine E.
        • Harter P.
        • Ray-Coquard I.
        • Pfisterer J.
        Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO).
        Cancer. 2009; 115: 1234-1244
        • Bristow R.E.
        • Tomacruz R.S.
        • Armstrong D.K.
        • Trimble E.L.
        • Montz F.J.
        Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.
        J Clin Oncol. 2002; 20: 1248-1259
        • Covens A.L.
        A critique of surgical cytoreduction in advanced ovarian cancer.
        Gynecol Oncol. 2000; 78: 269-274
        • Hacker N.F.
        Controversial aspects of cytoreductive surgery in epithelial ovarian cancer.
        Baillieres Clin Obstet Gynaecol. 1989; 3: 49-57
        • Tsolakidis D.
        • Amant F.
        • van G.T.
        • Leunen K.
        • Neven P.
        • Vergote I.
        Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB–IV epithelial ovarian cancer.
        Gynecol Oncol. 2010; 116: 489-496
        • Yildirim Y.
        • Sanci M.
        The feasibility and morbidity of distal pancreatectomy in extensive cytoreductive surgery for advanced epithelial ovarian cancer.
        Arch Gynecol Obstet. 2005; 272: 31-34
        • Crawford S.C.
        • Vasey P.A.
        • Paul J.
        • Hay A.
        • Davis J.A.
        • Kaye S.B.
        Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial.
        J Clin Oncol. 2005; 23: 8802-8811
        • du Bois A.
        • Rochon J.
        • Pfisterer J.
        • Hoskins W.J.
        Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review.
        Gynecol Oncol. 2009; 112: 422-436
        • Accounts Commission for Scotland
        Fighting the silent killer. Optimising ovarian cancer management in Scotland.
        (Available from:)
        • Vergote I.
        • de Oliviera C.
        • Dargent D.
        How to organize gynecologic oncology in the future: results of an international questionnaire?.
        Int J Gynecol Cancer. 1997; 7: 368-375
        • Marx C.
        • Bendixen A.
        • Hogdall C.
        • Ottosen C.
        • Kehlet H.
        • Ottesen B.
        Organisation and quality of primary surgical intervention for ovarian cancer in Denmark.
        Acta Obstet Gynecol Scand. 2007; 86: 1496-1502
        • Vernooij F.
        • Heintz A.P.
        • Witteveen P.O.
        • van der Heiden- van der Loo M.
        • Coebergh J.W.
        • van der Graaf Y.
        Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
        J Natl Cancer Inst. 2008; 100: 399-406
        • NHS Executive
        Guidance on commissioning cancer services. Improving outcomes in gynaecological cancers.
        (Available from:)
        • Gatta G.
        • Lasota M.B.
        • Verdecchia A.
        Survival of European women with gynaecological tumours, during the period 1978–1989.
        Eur J Cancer. 1998; 34 (EUROCARE Working Group): 2218-2225
        • Skirnisdottir I.
        • Sorbe B.
        Prognostic factors for surgical outcome and survival in 447 women treated for advanced (FIGO-stages III–IV) epithelial ovarian carcinoma.
        Int J Oncol. 2007; 30: 727-734
        • Kumpulainen S.
        • Kuoppala T.
        • Leminen A.
        • et al.
        Surgical treatment of ovarian cancer in different hospital categories–a prospective nation-wide study in Finland.
        Eur J Cancer. 2006; 42: 388-395
        • Petignat P.
        • Vajda D.
        • Joris F.
        • Obrist R.
        Surgical management of epithelial ovarian cancer at community hospitals: a population-based study.
        J Surg Oncol. 2000; 75: 19-23
        • Junor E.J.
        • Hole D.J.
        • McNulty L.
        • Mason M.
        • Young J.
        Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients.
        Br J Obstet Gynaecol. 1999; 106: 1130-1136
        • Bailey J.
        • Murdoch J.
        • Anderson R.
        • Weeks J.
        • Foy C.
        Stage III and IV ovarian cancer in the South West of England: five-year outcome analysis for cases treated in 1998.
        Int J Gynecol Cancer. 2006; 16: 25-29
        • Shylasree T.S.
        • Howells R.E.
        • Lim K.
        • et al.
        Survival in ovarian cancer in Wales: prior to introduction of all Wales guidelines.
        Int J Gynecol Cancer. 2006; 16: 1770-1776
        • Soegaard A.E.
        • Knudsen A.
        • Svarrer T.
        • et al.
        The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark.
        Gynecol Oncol. 2005; 99: 552-556
        • Engelen M.J.
        • Kos H.E.
        • Willemse P.H.
        • et al.
        Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
        Cancer. 2006; 106: 589-598
        • Paulsen T.
        • Kjaerheim K.
        • Kaern J.
        • Tretli S.
        • Trope C.
        Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals.
        Int J Gynecol Cancer. 2006; 16: 11-17
        • Marth C.
        • Hiebl S.
        • Oberaigner W.
        • Winter R.
        • Leodolter S.
        • Sevelda P.
        Influence of department volume on survival for ovarian cancer: results from a prospective quality assurance program of the Austrian Association for Gynecologic Oncology.
        Int J Gynecol Cancer. 2009; 19: 94-102
        • Oberaigner W.
        • Stuhlinger W.
        Influence of department volume on cancer survival for gynaecological cancers–a population-based study in Tyrol, Austria.
        Gynecol Oncol. 2006; 103: 527-534
        • Kumpulainen S.
        • Sankila R.
        • Leminen A.
        • et al.
        The effect of hospital operative volume, residual tumor and first-line chemotherapy on survival of ovarian cancer – a prospective nation-wide study in Finland.
        Gynecol Oncol. 2009; 115: 199-203
        • du Bois A.
        • Rochon J.
        • Lamparter C.
        • Pfisterer J.
        Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer.
        Int J Gynecol Cancer. 2005; 15: 183-191
        • Weide R.
        • Arndt M.
        • Pandorf A.
        • Heymanns J.
        • Thomalla J.
        • Koppler H.
        Ovarian cancer treatment reality in northern Rheinland-Pfalz (Germany). Suboptimal surgical treatment as a possible cause for inferior survival.
        Onkologie. 2007; 30: 611-617
        • Munstedt K.
        • von G.R.
        • Misselwitz B.
        • Zygmunt M.
        • Stillger R.
        • Kunzel W.
        Centralizing surgery for gynecologic oncology–a strategy assuring better quality treatment?.
        Gynecol Oncol. 2003; 89: 4-8
        • Stockton D.
        • Davies T.
        Multiple cancer site comparison of adjusted survival by hospital of treatment: an East Anglian study.
        Br J Cancer. 2000; 82: 208-212
        • Wolfe C.D.
        • Tilling K.
        • Raju K.S.
        Management and survival of ovarian cancer patients in south east England.
        Eur J Cancer. 1997; 33: 1835-1840
        • Akeson M.
        • Jakobsen A.M.
        • Zetterqvist B.M.
        • Holmberg E.
        • Brannstrom M.
        • Horvath G.
        A population-based 5-year cohort study including all cases of epithelial ovarian cancer in western Sweden: 10-year survival and prognostic factors.
        Int J Gynecol Cancer. 2009; 19: 116-123
        • Vergote I.
        VWOG-Oncologieregistratie 1998–2002 deel 5: ovariumcarcinoom.
        Tijdschrift Voor Geneeskunde. 2006; 62: 853-858
        • Munstedt K.
        • von G.R.
        • Zygmunt M.
        • Misselwitz B.
        • Stillger R.
        • Kunzel W.
        Shortcomings and deficits in surgical treatment of gynecological cancers: a German problem only?.
        Gynecol Oncol. 2002; 86: 337-343
        • Pectasides D.
        • Papaxoinis G.
        • Fountzilas G.
        • et al.
        Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative oncology Group (HeCOG).
        Anticancer Res. 2009; 29: 745-751
        • Verleye L.
        • Ottevanger P.B.
        • van der Graaf W.
        • Reed N.S.
        • Vergote I.
        EORTC-GCG process quality indicators for ovarian cancer surgery.
        Eur J Cancer. 2009; 45: 517-526
        • Gagliardi A.R.
        • Fung M.F.
        • Langer B.
        • Stern H.
        • Brown A.D.
        Development of ovarian cancer surgery quality indicators using a modified Delphi approach.
        Gynecol Oncol. 2005; 97: 446-456
        • National Institutes of Health Consensus Development Conference Statement
        Ovarian cancer: screening, treatment, and follow-up.
        Gynecol Oncol. 1994; 55: S4-S14
        • Heintz A.P.
        • Odicino F.
        • Maisonneuve P.
        • et al.
        Carcinoma of the ovary. FIGO 6th Annual report on the results of treatment in gynecological cancer.
        Int J Gynaecol Obstet. 2006; 95: S161-S192
        • Bosze P.
        • Bast R.C.
        • Berchuck A.
        • et al.
        Conseusus statements on prognostic factors in epithelial ovarian carcinoma. Report of the Consensus Meeting organized by the European Society of Gynaecological Oncology, ESGO.
        Eur J Gynaecol Oncol. 2000; 21: 513-526
        • The Society of Gynecologic Oncologists
        Guidelines for referral to a gynecologic oncologist: rationale and benefits.
        Gynecol Oncol. 2000; 78: S1-S13
        • Cabana M.D.
        • Rand C.S.
        • Powe N.R.
        • et al.
        Why don’t physicians follow clinical practice guidelines? A framework for improvement.
        JAMA. 1999; 282: 1458-1465
        • Eisenkop S.M.
        • Spirtos N.M.
        What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?.
        Gynecol Oncol. 2001; 82: 489-497
        • Grilli R.
        • Alexanian A.
        • Apolone G.
        • et al.
        The impact of cancer treatment guidelines on actual practice in Italian general hospitals: the case of ovarian cancer.
        Ann Oncol. 1990; 1: 112-118
        • Benson K.
        • Hartz A.J.
        A comparison of observational studies and randomized, controlled trials.
        N Engl J Med. 2000; 342: 1878-1886
        • Concato J.
        • Shah N.
        • Horwitz R.I.
        Randomized, controlled trials, observational studies, and the hierarchy of research designs.
        N Engl J Med. 2000; 342: 1887-1892
        • Cibula D.
        • Kesic V.
        Surgical education and training in gynecologic oncology I: European perspective.
        Gynecol Oncol. 2009; 114: S52-S55
        • Verleye L.
        • Ottevanger P.B.
        • Vergote I.
        Surgical program building in advanced ovarian cancer: European perspective.
        Gynecol Oncol. 2009; 114: S10-S14
        • Gouveia J.
        • Coleman M.P.
        • Haward R.
        • et al.
        Improving cancer control in the European Union: conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007.
        Eur J Cancer. 2008; 44: 1457-1462
        • Albreht T.
        • McKee M.
        • Alexe D.M.
        • Coleman M.P.
        • Martin-Moreno J.M.
        Making progress against cancer in Europe in 2008.
        Eur J Cancer. 2008; 44: 1451-1456
        • Crawford S.M.
        • Brunskill P.J.
        Centralisation of services for the management of ovarian cancer: arguments against.
        BJOG. 2007; 114: 1183-1185
        • Petignat P.
        • Vlastos G.
        Why do ovarian cancer patients not consult a gynecologic oncologist?.
        Gynecol Oncol. 2002; 87: 157
        • Akeson M.
        • Zetterqvist B.M.
        • Holmberg E.
        • Horvath G.
        Improved survival with clinical guidelines? Evaluation of a quality register linked to clinical guidelines for ovarian cancer in the western health care region in Sweden between 1 September 1993 and 1 June 1998.
        Acta Obstet Gynecol Scand. 2005; 84: 1113-1118
        • Tetsche M.S.
        • Norgaard M.
        • Jacobsen J.
        • Andersen E.S.
        • Lundorff P.
        • Blaakaer J.
        • et al.
        Improved survival of patients with ovarian cancer in Northern Denmark, 1985–2004.
        Eur J Gynaecol Oncol. 2006; 27: 119-122
        • Vernooij F.
        • Heintz A.P.
        • Coebergh J.W.
        • Massuger L.F.
        • Witteveen P.O.
        • van der Graaf Y.
        Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands.
        Gynecol Oncol. 2009; 112: 455-461